West Pharmaceutical Services Research and Development Expenses 2010-2024 | WST

West Pharmaceutical Services annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • West Pharmaceutical Services research and development expenses for the quarter ending September 30, 2024 were $0.016B, a 5.49% decline year-over-year.
  • West Pharmaceutical Services research and development expenses for the twelve months ending September 30, 2024 were $69M, a 4.7% increase year-over-year.
  • West Pharmaceutical Services annual research and development expenses for 2023 were $0.068B, a 16.92% increase from 2022.
  • West Pharmaceutical Services annual research and development expenses for 2022 were $0.059B, a 10.8% increase from 2021.
  • West Pharmaceutical Services annual research and development expenses for 2021 were $0.053B, a 12.58% increase from 2020.
West Pharmaceutical Services Annual Research and Development Expenses
(Millions of US $)
2023 $68
2022 $59
2021 $53
2020 $47
2019 $39
2018 $40
2017 $39
2016 $37
2015 $34
2014 $37
2013 $38
2012 $33
2011 $29
2010 $24
2009 $20
West Pharmaceutical Services Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $16
2024-06-30 $18
2024-03-31 $18
2023-12-31 $18
2023-09-30 $16
2023-06-30 $17
2023-03-31 $17
2022-12-31 $16
2022-09-30 $14
2022-06-30 $14
2022-03-31 $15
2021-12-31 $14
2021-09-30 $13
2021-06-30 $14
2021-03-31 $12
2020-12-31 $13
2020-09-30 $13
2020-06-30 $11
2020-03-31 $11
2019-12-31 $10
2019-09-30 $9
2019-06-30 $10
2019-03-31 $10
2018-12-31 $10
2018-09-30 $10
2018-06-30 $11
2018-03-31 $10
2017-12-31 $10
2017-09-30 $9
2017-06-30 $10
2017-03-31 $10
2016-12-31 $10
2016-09-30 $9
2016-06-30 $9
2016-03-31 $9
2015-12-31 $10
2015-09-30 $9
2015-06-30 $8
2015-03-31 $8
2014-12-31 $8
2014-09-30 $10
2014-06-30 $10
2014-03-31 $10
2013-12-31 $10
2013-09-30 $10
2013-06-30 $10
2013-03-31 $9
2012-12-31 $9
2012-09-30 $8
2012-06-30 $8
2012-03-31 $8
2011-12-31 $7
2011-09-30 $8
2011-06-30 $7
2011-03-31 $7
2010-12-31 $7
2010-09-30 $6
2010-06-30 $6
2010-03-31 $5
2009-12-31 $6
2009-09-30 $5
2009-06-30 $5
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.359B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.221B 20.52
Becton Dickinson (BDX) United States $68.842B 18.04
Cardinal Health (CAH) United States $30.559B 16.57
Labcorp (LH) United States $19.953B 16.54
Cooper (COO) United States $18.615B 25.21
Align Technology (ALGN) United States $16.739B 32.03
Henry Schein (HSIC) United States $9.129B 17.39
Merit Medical Systems (MMSI) United States $5.997B 30.62
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
Patterson (PDCO) United States $2.729B 14.57
CONMED (CNMD) United States $2.091B 17.45
STAAR Surgical (STAA) United States $1.098B 40.53
Lifevantage (LFVN) United States $0.317B 42.18
Pro-Dex (PDEX) United States $0.145B 28.80